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J Vasc Surg 2013;57:934-41.Submitted Sep 2, 2012; accepted Feb 16, 2013.INVITED COMMENTARYMaciej L. Dryjski, MD, PhD, Buffalo, NYOver the years, several studies have been published comparing
renal function after endovascular aneurysm repair (EVAR) and
open repair, as well as EVAR with transrenal and infrarenal graft
ﬁxation. Results of these investigations have been inconsistent,
which could be attributed to both the methodology itself as well
as to an often multifactorial etiology of chronic renal failure in
these patients. Dr Antonello and colleagues’ work distinguishes
itself with a very long follow-up period and a more sensitive
method to assess renal function. The study is prospective and
non-randomized, with less than 40% of patients being recruited
to the EVAR cohort. The traditional approach was preferred in
patients with long-life expectancy and individuals with unsuitable
anatomy for EVAR, applying very conservative anatomical exclu-
sion criteria for good-risk patients and different, much less strin-
gent criteria for patients at high risk. In addition, there were
signiﬁcantly more American Society of Anaesthesiologists class
IV patients and patients with coronary and pulmonary disease
recruited into the EVAR group (4% vs 26%, 34% vs 53%, and
20% vs 47%, respectively). Thus, it seems that there was a bias in
patient selection which ultimately may have altered the outcome
of the analysis. Furthermore, the authors implied that at least20% decrease of glomular ﬁltration rate calculated with renal perfu-
sion scintigraphy (RPS) is needed to be considered relevant. In
EVAR patients, the decrease was 11% at 108 months, and in the
EVAR cohort requiring reinterventions, the mean RPS decrease
was no more than 14%. The only signiﬁcant decrease in RPS was
limited to one kidney and most likely resulted from microemboli-
zation during the procedure. It remains unclear what clinical
signiﬁcance a slight decrease in RPS may have on overall renal
function and ultimately a patient’s life expectancy.
Finally, the follow-up protocol required at least four computed
tomography angiographies in the ﬁrst year in addition to a peri-
operative angiogram. The cumulative volume of contrast media
given to these patients is probably the single most important factor
affecting renal function. This is also supported by the fact that
patients exposed for multiple reinterventions, which often require
administration of signiﬁcant volume of dye, were particularly prone
todevelop renal insufﬁciency.DrAntonello indicated that, as a result
of this study, he modernized his surveillance protocol, replacing
frequent computed tomography angiographies with ultrasound
exams, and I think this is the most important take-home lesson
from this article.
